CD274 and neoplasm: Three separate rounds of anti-PD-L1 immunohistochemistry using the antibody clones “SP142”, “22C3”, and “28–8” were performed, resulting in a tumor proportion score (TPS) of 0% and a combined positivity score (CPS) of 0 for the laryngeal cancer (Fig. 2B).